CN100384413C - 用于治疗尿失禁的选择的阿片样物质与毒蝇碱拮抗剂的组合 - Google Patents

用于治疗尿失禁的选择的阿片样物质与毒蝇碱拮抗剂的组合 Download PDF

Info

Publication number
CN100384413C
CN100384413C CNB028227794A CN02822779A CN100384413C CN 100384413 C CN100384413 C CN 100384413C CN B028227794 A CNB028227794 A CN B028227794A CN 02822779 A CN02822779 A CN 02822779A CN 100384413 C CN100384413 C CN 100384413C
Authority
CN
China
Prior art keywords
alkyl
methyl
dimethylamino
perhaps
och
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028227794A
Other languages
English (en)
Chinese (zh)
Other versions
CN1589140A (zh
Inventor
T·克里斯托夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of CN1589140A publication Critical patent/CN1589140A/zh
Application granted granted Critical
Publication of CN100384413C publication Critical patent/CN100384413C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNB028227794A 2001-09-18 2002-09-18 用于治疗尿失禁的选择的阿片样物质与毒蝇碱拮抗剂的组合 Expired - Fee Related CN100384413C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146275.1 2001-09-18
DE10146275A DE10146275A1 (de) 2001-09-18 2001-09-18 Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Publications (2)

Publication Number Publication Date
CN1589140A CN1589140A (zh) 2005-03-02
CN100384413C true CN100384413C (zh) 2008-04-30

Family

ID=7699618

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028227794A Expired - Fee Related CN100384413C (zh) 2001-09-18 2002-09-18 用于治疗尿失禁的选择的阿片样物质与毒蝇碱拮抗剂的组合

Country Status (21)

Country Link
US (2) US20040242617A1 (https=)
EP (1) EP1429754B1 (https=)
JP (1) JP4511176B2 (https=)
KR (1) KR100891438B1 (https=)
CN (1) CN100384413C (https=)
AT (1) ATE383854T1 (https=)
AU (1) AU2002342707B2 (https=)
BR (1) BR0212714A (https=)
CA (1) CA2460655C (https=)
DE (2) DE10146275A1 (https=)
EC (1) ECSP045025A (https=)
ES (1) ES2299608T3 (https=)
HU (1) HUP0401485A3 (https=)
IL (2) IL160894A0 (https=)
MX (1) MXPA04002510A (https=)
NO (1) NO333016B1 (https=)
NZ (1) NZ531777A (https=)
PL (1) PL209272B1 (https=)
RU (1) RU2305562C2 (https=)
WO (1) WO2003024444A1 (https=)
ZA (1) ZA200402853B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
DE10224108A1 (de) * 2002-05-29 2004-01-29 Grünenthal GmbH 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung
US7410965B2 (en) 2002-05-29 2008-08-12 Gruenenthal Gmbh Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
ES2288641T3 (es) * 2002-12-20 2008-01-16 Dynogen Pharmaceuticals Inc. Metodo para tratar trastornos indoloros de la vejiga usando moduladores de canales del calcio de la subunidad alfa2-delta.
DE602004003172T2 (de) * 2003-03-21 2007-09-27 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
DE10356362A1 (de) * 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen
AU2005245403B2 (en) * 2004-05-14 2012-04-19 Janssen Pharmaceutica N.V. Carboxamido opioid compounds
DE102005009217A1 (de) * 2005-02-25 2006-08-31 Grünenthal GmbH Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen
US20070032551A1 (en) * 2005-07-22 2007-02-08 Gruenenthal Gmbh Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
JP5323480B2 (ja) * 2005-07-22 2013-10-23 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ３−［２−（ジメチルアミノ）メチル−（シクロヘキシ−１−イル）］−フェノールのＨＣｌ多形体
US7884247B2 (en) * 2005-07-22 2011-02-08 Gruenenthal Gmbh Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
DE102007022790A1 (de) 2007-05-11 2008-11-20 Grünenthal GmbH Axomadol zur Schmerzbehandlung bei Arthrose
BRPI0921725A2 (pt) * 2008-10-30 2016-01-05 Grüenthal GmbH formas de dosagem potentes do tapentadol
WO2011110595A1 (de) 2010-03-10 2011-09-15 Grünenthal GmbH Kristalline salze und/oder cokristalle von o-desmethyltramadol
CA2798884C (en) 2010-05-10 2016-09-13 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
AU2011252039B2 (en) 2010-05-10 2014-06-12 Euro-Celtique S.A. Pharmaceutical compositions comprising hydromorphone and naloxone
CN103002881B (zh) 2010-05-10 2015-09-02 欧洲凯尔特公司 载有活性剂的颗粒与额外活性剂的组合
CN103040828B (zh) * 2013-01-07 2015-12-02 常州康普药业有限公司 复方地芬诺酯片及其制备方法
WO2015071380A1 (en) 2013-11-13 2015-05-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857194A (en) * 1957-07-05 1960-12-29 Clinical Products Ltd Therapeutic agents comprising ion-exchange resins
DE3129982A1 (de) * 1981-07-29 1983-02-17 Jutta 8200 Rosenheim Meyer "antiallergikum"
WO1996027375A2 (en) * 1995-03-03 1996-09-12 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
WO2001024783A2 (de) * 1999-10-05 2001-04-12 Grünenthal GmbH Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
WO2001062236A2 (en) * 2000-02-24 2001-08-30 Pharmacia & Upjohn Company New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127065C (https=) 1964-04-22
US5736577A (en) 1995-01-31 1998-04-07 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
DE3012837A1 (de) * 1979-04-10 1980-10-30 Sandoz Ag Analgetische und myotonolytische praeparate
US5073560A (en) 1990-07-20 1991-12-17 Fisons Corporation Spiro-isoxazolidine derivatives as cholinergic agents
DE4041559A1 (de) 1990-12-22 1992-06-25 Boehringer Ingelheim Kg Neue wirkstoffkombinationen
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
CN1054850C (zh) * 1993-07-30 2000-07-26 德尔塔药物公司 用于治疗的哌嗪化合物
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
JP2000515525A (ja) 1996-07-19 2000-11-21 アベーグ，グンナー 尿と胃腸の疾患の治療におけるｓ（―）―トルテロジン
EP1005861B1 (en) * 1997-04-11 2005-06-29 Nippon Shinyaku Co., Ltd. Remedies for frequent urination and urinary incontinence
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857194A (en) * 1957-07-05 1960-12-29 Clinical Products Ltd Therapeutic agents comprising ion-exchange resins
DE3129982A1 (de) * 1981-07-29 1983-02-17 Jutta 8200 Rosenheim Meyer "antiallergikum"
WO1996027375A2 (en) * 1995-03-03 1996-09-12 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
WO2001024783A2 (de) * 1999-10-05 2001-04-12 Grünenthal GmbH Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
WO2001062236A2 (en) * 2000-02-24 2001-08-30 Pharmacia & Upjohn Company New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Genitourinary tract patent update.". SMITH C.P. ET AL.EXPERT OPINION ON THERAPEUTIC PATENTS,Vol.11 No.1. 2001 *
"INHIBITION OF URINARY BLADDER CONTRACTIONS BYA SPINAL ACTION OF MORPHINE AND OTHER OPIOIDS". DRAY A ET AL.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,Vol.231 No.2. 1984 *
"Recent approaches to the treatment of urinary incontinence:A survey of patent activity from 1995 to 1998.". BUTERA J.A. ET AL.EXPERT OPINION ON THERAPEUTIC PATENTS,Vol.8 No.8. 1998 *

Also Published As

Publication number Publication date
CA2460655A1 (en) 2003-03-27
WO2003024444A1 (de) 2003-03-27
HUP0401485A3 (en) 2008-04-28
DE50211566D1 (de) 2008-03-06
NZ531777A (en) 2006-11-30
IL160894A0 (en) 2004-08-31
ATE383854T1 (de) 2008-02-15
ES2299608T3 (es) 2008-06-01
KR100891438B1 (ko) 2009-04-03
RU2004111788A (ru) 2005-06-10
EP1429754B1 (de) 2008-01-16
JP4511176B2 (ja) 2010-07-28
AU2002342707B2 (en) 2006-10-12
EP1429754A1 (de) 2004-06-23
PL369235A1 (en) 2005-04-18
NO20041059L (no) 2004-05-12
RU2305562C2 (ru) 2007-09-10
BR0212714A (pt) 2004-08-03
ZA200402853B (en) 2005-02-23
HUP0401485A2 (hu) 2004-11-29
NO333016B1 (no) 2013-02-18
HK1075205A1 (zh) 2005-12-09
JP2005507387A (ja) 2005-03-17
DE10146275A1 (de) 2003-04-24
US20120016023A1 (en) 2012-01-19
ECSP045025A (es) 2004-04-28
KR20040044953A (ko) 2004-05-31
US8946290B2 (en) 2015-02-03
IL160894A (en) 2010-04-29
MXPA04002510A (es) 2004-05-31
CA2460655C (en) 2012-02-07
US20040242617A1 (en) 2004-12-02
CN1589140A (zh) 2005-03-02
PL209272B1 (pl) 2011-08-31

Similar Documents

Publication Publication Date Title
CN100384413C (zh) 用于治疗尿失禁的选择的阿片样物质与毒蝇碱拮抗剂的组合
ES2304659T3 (es) Utilizacion de (1rs,3rs,6rs)-6-dimetilaminometil-1-(3-metoxifenil)-1,3-ciclohexanodiol para el tratamiento del dolor inflamatorio.
WO2003099268A1 (de) Kombination ausgewählter opioide mit anderen wirkstoffen zur therapie der harninkontinenz
RU2286768C2 (ru) Применение 1-фенил-3-диметиламинопропановых соединений для терапии недержания мочи
US20180235909A1 (en) Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain
CN1321634C (zh) 6－二甲基氨基甲基－1－苯基－环己烷化合物治疗尿失禁的用途
RU2279875C2 (ru) Применение замещенных 6-диметиламинометил-1-фенилциклогексановых соединений для терапии недержания мочи
EP2849747A1 (en) Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a nsar
JP4271142B2 (ja) １−ジメチルアミノ−３−（３−メトキシ−フェニル）−２−メチル−ペンタン−３−オール及び３−（３−ジメチルアミノ−１−エチル−１−ヒドロキシ−２−メチル−プロピル）−フェノールの有効物質塩及びエステル
US20050143355A1 (en) Pharmaceutically active salts and esters of 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol and 3- (3-dimethylamino-1-ethyl-1-hydroxy-2-methylpropyl)-phenol and methods of using same
US20050137194A1 (en) Combination of selected opioids with other active compounds for treatment of urinary incontinence
HK1075205B (en) Combination of selected opioids with muscarine antagonists for treating urinary incontinence
US20050137145A1 (en) Metabolites of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and their use in the treatment of urinary incontinence
DE10224624A1 (de) Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
HK1224570A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1075205

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1075205

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080430

Termination date: 20150918

EXPY Termination of patent right or utility model